Jazmati, Danny, Butzer, Sarina, Hero, Barbara, Doyen, Jerome, Khalil, Dalia Ahmad, Steinmeier, Theresa, Schleithoff, Stefanie Schulze, Eggert, Angelika, Simon, Thorsten and Timmermann, Beate . Long-term follow-up of children with neuroblastoma receiving radiotherapy to metastatic lesions within the German Neuroblastoma Trials NB97 and NB 2004. Strahlenther. Onkol.. HEIDELBERG: SPRINGER HEIDELBERG. ISSN 1439-099X

Full text not available from this repository.

Abstract

Purpose Neuroblastoma (NB) is the most common extracranial solid malignancy during childhood. Despite a multimodal treatment approach, the prognosis of patients with metastatic NB is not satisfactory. Although radiotherapy (RT) has become an integral part of treatment of the primary tumor, the role of RT in osteomedullary lesions is not well defined. A retrospective analysis was conducted to evaluate the impact of RT for metastatic sites in children with high-risk NB. Methods All patients with stage 4 NB from the prospective, multicenter NB trials NB97 and NB2004 who received RT to metastatic sites during frontline treatment were included in this retrospective analysis. Results A total of 18 children were irradiated with a median dose of 36 Gray (Gy; range 20-45 Gy) to one or more (range 1-3) osteomedullary metastases with or without concomitant RT to the primary tumor site. The median follow-up time was 149 months (range 55-220) in survivors. At 5 years, local relapse-free survival (LRFS) at irradiated metastatic sites and metastases-free survival (MFS) at distant, non-irradiated site rates were 51.4 and 39.9%, respectively. The estimated overall survival (OS) rate at 5 years was 49.4%. No high-grade acute or late toxicity and no secondary malignancy was reported. Conclusion RT to metastases is feasible for patients with stage 4 NB. However, an impact of RT to residual metastatic sites on outcome was not found. Studies with larger cohorts or prospective trials would be desirable in order to elucidate the role of RT for metastases.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Jazmati, DannyUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Butzer, SarinaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Hero, BarbaraUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Doyen, JeromeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Khalil, Dalia AhmadUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Steinmeier, TheresaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Schleithoff, Stefanie SchulzeUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Eggert, AngelikaUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Simon, ThorstenUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Timmermann, BeateUNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-308425
DOI: 10.1007/s00066-020-01718-5
Journal or Publication Title: Strahlenther. Onkol.
Publisher: SPRINGER HEIDELBERG
Place of Publication: HEIDELBERG
ISSN: 1439-099X
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
HIGH-RISK NEUROBLASTOMA; RADIATION-THERAPY; INDUCTION CHEMOTHERAPY; SITES; CONSOLIDATION; DISEASEMultiple languages
Oncology; Radiology, Nuclear Medicine & Medical ImagingMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/30842

Downloads

Downloads per month over past year

Altmetric

Export

Actions (login required)

View Item View Item